Panacea Innovation Ltd → Connect Biopharma Holdings Ltd CNTB

Stake: 25.10% Shares: 13,950,000 CUSIP: 207523101 Class: Ordinary Shares

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 11/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -13.8%

Filer track record (3 filings): 0% 90d win rate, -13.8% 90d edge
High conviction ownership stake (25.1%)
Short interest building (+10.2% vs prior settlement)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.73

3,857,756 shares short · +10.2% vs prior

Post-Filing Returns · since 2025-07-21 on CNTB

+1 day

+19.0%

+5 days

+4.0%

+30 days

-16.5%

+60 days

-21.5%

+90 days

-12.0%

+180 days

+15.0%

Anchor price 2.00 on closest trading day on/after 2025-07-21. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Connect Biopharma Holdings Ltd

Filed	Form	Filer	Stake	Shares
2026-10-06	SCHEDULE 13G	BML Investment Partners, L.P.	—	—	view →
2026-04-01	SCHEDULE 13D/A	Panacea Innovation Ltd	21.20%	13,160,000	view →
2024-07-01	SC	Panacea Innovation Ltd	—	—	view →
2021-06-07	SC	RA CAPITAL MANAGEMENT, L.P.	—	—	view →

Other Filings by Panacea Innovation Ltd

Filed	Form	Issuer	Stake	Shares
2026-05-11	SCHEDULE 13D/A	Atara Biotherapeutics, Inc. ATRA	—	1,318,894	view →
2026-04-01	SCHEDULE 13D/A	Connect Biopharma Holdings Limited CNTB	21.20%	13,160,000	view →
2024-07-01	SC	Connect Biopharma Holdings Ltd CNTB	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →